NO20052950L - Ny fremgangsmate for fremstilling av imidazolforbindelser - Google Patents

Ny fremgangsmate for fremstilling av imidazolforbindelser

Info

Publication number
NO20052950L
NO20052950L NO20052950A NO20052950A NO20052950L NO 20052950 L NO20052950 L NO 20052950L NO 20052950 A NO20052950 A NO 20052950A NO 20052950 A NO20052950 A NO 20052950A NO 20052950 L NO20052950 L NO 20052950L
Authority
NO
Norway
Prior art keywords
preparation
new process
imidazole compounds
imidazole
compounds
Prior art date
Application number
NO20052950A
Other languages
English (en)
Other versions
NO20052950D0 (no
NO330342B1 (no
Inventor
Paulus Franciscus Corneli Meij
Jan-Maarten Verbeek
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of NO20052950D0 publication Critical patent/NO20052950D0/no
Publication of NO20052950L publication Critical patent/NO20052950L/no
Publication of NO330342B1 publication Critical patent/NO330342B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20052950A 2002-11-18 2005-06-16 Ny fremgangsmate for fremstilling av imidazolylforbindelser NO330342B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02079838 2002-11-18
PCT/EP2003/050841 WO2004046116A1 (en) 2002-11-18 2003-11-17 Novel process for the preparation of imidazolyl compounds

Publications (3)

Publication Number Publication Date
NO20052950D0 NO20052950D0 (no) 2005-06-16
NO20052950L true NO20052950L (no) 2005-08-15
NO330342B1 NO330342B1 (no) 2011-03-28

Family

ID=32319633

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052950A NO330342B1 (no) 2002-11-18 2005-06-16 Ny fremgangsmate for fremstilling av imidazolylforbindelser

Country Status (25)

Country Link
EP (1) EP1565445B1 (no)
JP (1) JP4611026B2 (no)
KR (1) KR20050075026A (no)
CN (1) CN100349873C (no)
AR (1) AR041955A1 (no)
AT (1) ATE340783T1 (no)
AU (1) AU2003296762B2 (no)
BR (1) BR0316308A (no)
CA (1) CA2504614C (no)
DE (1) DE60308720T2 (no)
DK (1) DK1565445T3 (no)
ES (1) ES2273088T3 (no)
HK (1) HK1081188A1 (no)
HR (1) HRP20050376A2 (no)
IL (1) IL168258A (no)
MX (1) MXPA05005261A (no)
NO (1) NO330342B1 (no)
PL (1) PL376743A1 (no)
PT (1) PT1565445E (no)
RU (1) RU2314296C2 (no)
SA (1) SA03240414B1 (no)
SI (1) SI1565445T1 (no)
UA (1) UA79655C2 (no)
WO (1) WO2004046116A1 (no)
ZA (1) ZA200503425B (no)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059491T3 (es) * 1987-06-29 1994-11-16 Duphar Int Res Derivados de indol con anillos condensados.

Also Published As

Publication number Publication date
KR20050075026A (ko) 2005-07-19
AR041955A1 (es) 2005-06-01
NO20052950D0 (no) 2005-06-16
UA79655C2 (en) 2007-07-10
ATE340783T1 (de) 2006-10-15
AU2003296762B2 (en) 2010-03-18
EP1565445A1 (en) 2005-08-24
AU2003296762A1 (en) 2004-06-15
JP2006512322A (ja) 2006-04-13
DE60308720D1 (de) 2006-11-09
HRP20050376A2 (en) 2006-02-28
WO2004046116A1 (en) 2004-06-03
CA2504614A1 (en) 2004-06-03
PL376743A1 (pl) 2006-01-09
HK1081188A1 (en) 2006-05-12
CN1714082A (zh) 2005-12-28
MXPA05005261A (es) 2005-07-25
DE60308720T2 (de) 2007-01-11
IL168258A (en) 2010-05-31
ZA200503425B (en) 2007-02-28
JP4611026B2 (ja) 2011-01-12
EP1565445B1 (en) 2006-09-27
CA2504614C (en) 2010-09-28
NO330342B1 (no) 2011-03-28
RU2005119155A (ru) 2006-01-20
SI1565445T1 (sl) 2007-02-28
DK1565445T3 (da) 2007-01-29
PT1565445E (pt) 2007-01-31
ES2273088T3 (es) 2007-05-01
RU2314296C2 (ru) 2008-01-10
CN100349873C (zh) 2007-11-21
BR0316308A (pt) 2005-09-27
SA03240414B1 (ar) 2006-12-05

Similar Documents

Publication Publication Date Title
NO20050136D0 (no) Fremgangsmate for fremstilling av mikropartikler
NO20033579L (no) Fremgangsmåte for syntetisering av camptothecin relaterte forbindelser
NO20051957D0 (no) Ny fremgangsmate for fremstillingen av roflumilast
NO20054317D0 (no) Fremgangsmate for homogenisering av polyolefin-DRA-midler
NO20043586L (no) Fremgangsmate for fremstilling av organiske forbindelser
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
IL174238A0 (en) Process for the preparation of n- amino substituted heterocyclic compounds
NO20040292L (no) Fremgangsmate for fremstilling av 4-aminodifenylamin
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
NO20034003D0 (no) Fremgangsmåte for fremstilling av imidazol-forbindelser
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20033408D0 (no) Fremgangsmåte for fremstilling av krystallinske nanopartikler
NO20043623L (no) Fremgangsmate for fremstilling av papir
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
NO20052197D0 (no) Fremgangsmate for fremstilling av pyrazol
NO20034597L (no) Fremgangsmate for fremstilling av cantaxantin
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
NO20052396D0 (no) Fremgangsmate for fremstilling av spirolactonforbindelser
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine
NO20033147D0 (no) Fremgangsmate for fremstilling av rent ondansetronhydrogenkloriddihydrat
NO20052392L (no) Fremgangsmate for fremstilling av acetylenforbindelser.
NO20052950D0 (no) Ny fremgangsmate for fremstilling av imidazolforbindelser
ITMI20030018A1 (it) Procedimento per la preparazione di composti mono-
NO20043455L (no) Fremgangsmate for fremstilling av 7alfa-metylsteroider
DK1656340T3 (da) Fremgangsmåde til fremstilling af 1-carbamoylcykloalkylcarboxylsyreforbindelser

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees